EMA
label_change
· 2019-07-26
Updated restrictions for Gilenya: multiple sclerosis medicine not to be used in pregnancy
Summary
The European Medicines Agency updates restrictions for Gilenya (fingolimod) to prohibit use during pregnancy due to potential fetal harm, reinforcing guidance o…
Upgrade for the full analysis, importance score, and drug timeline.